2. Search Result
Search Result
Results for "

Syringic acid

" in MedChemExpress (MCE) Product Catalog:

5

Inhibitors & Agonists

2

Natural
Products

1

Isotope-Labeled Compounds

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-N0339
    Syringic acid

    		Endogenous Metabolite Bacterial Metabolic Disease
    Syringic acid is correlated with high antioxidant activity and inhibition of LDL oxidation.
    Syringic acid
  • HY-N0339R
    Syringic acid (Standard)

    		Endogenous Metabolite Bacterial Metabolic Disease
    Syringic acid (Standard) is the analytical standard of Syringic acid. This product is intended for research and analytical applications. Syringic acid is correlated with high antioxidant activity and inhibition of LDL oxidation.
    Syringic acid (Standard)
  • HY-N6654
    Syringyl Alcohol

    Syringic Alcohol

    		 Drug Derivative Others
    Syringyl Alcohol (Syringic Alcohol) is a derivate of phenol comprises both phenolic and alcoholic functional groups. Syringyl Alcohol is a probe molecule for the evaluation of the catalytic performance of various carbonaceous nanomaterials (CNMs) .
    Syringyl Alcohol
  • HY-N0339S
    Syringic acid-d6

    		Bacterial Endogenous Metabolite Metabolic Disease
    Syringic acid-d6 is the deuterium labeled Syringic acid[1]. Syringic acid is correlated with high antioxidant activity and inhibition of LDL oxidation[2][3].
    Syringic acid-d6
  • HY-16387
    PF 00337210

    		VEGFR Others
    PF-00337210 is a potent and selective inhibitor of VEGFRs, designed for treating age-related macular degeneration via intravitreal injection. The formulation strategy focused on developing an ophthalmic solution that would precipitate upon injection into the vitreous, ensuring sustained drug delivery. Challenges included maintaining low dosing volumes, selecting safe excipients for intravitreal use, and addressing the drug's unique physicochemical properties. The final formulation, an isotonic solution in a citrate-buffered vehicle with NaCl, demonstrated stability, potency, and recovery through intravitreal dosing syringes. It formed a depot upon injection into vitreous humor, representing a novel nonpolymeric in situ-forming depot formulation for intravitreal drug delivery .
    PF 00337210

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: